Article Text

Download PDFPDF
Correspondence
Positron emission tomography in giant cell arteritis: a new diagnostic tool?
  1. P I Novikov,
  2. A D Meshkov,
  3. S V Moiseev
  1. Clinic of Nephrology, Internal and Occupational Diseases, First Moscow State Medical University, Moscow, Russia
  1. Correspondence to Professor S V Moiseev, Rossolimo, Clinic of Nephrology, Internal and Occupational Diseases, First Moscow State Medical University, 11/5, Moscow 119435, Russia; clinpharm{at}mtu-net.ru

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

In a prospective case–control study recently published in the Annals of Rheumatic Diseases, Prieto-González et al1 have shown a high sensitivity and specificity of positron emission tomography (PET)/CT with 18fluorodeoxyglucose (FDG) in 32 patients with newly diagnosed, biopsy-proven giant cell arteritis (GCA). Using receiver–operator characteristic curves (ROC) analysis, the authors determined cut-off maximal standardised uptake values (SUVm) to detect vascular inflammation by PET/CT. The sensitivity and specificity of PET/CT obtained in this study was close to that calculated in a recent meta-analysis of mostly retrospective studies.2

We used PET with FDG for diagnosis and assessment of …

View Full Text

Footnotes

  • Contributors All authors participated in the follow-up of patients.

  • Competing interests None.

  • Provenance and peer review Not commissioned; internally peer reviewed.

Linked Articles

  • Electronic pages
    Sergio Prieto-González Marina Depetris Ana García-Martínez Georgina Espígol-Frigolé Itziar Tavera-Bahillo Marc Corbera-Bellalta Ester Planas-Rigol Marco A Alba José Hernández-Rodríguez Josep M Grau Franciso Lomeña Maria C Cid